The metabolic syndrome as a risk factor for colorectal cancer

Objective. To evaluate the prognostic significance of metabolic syndrome (MS) in the development of colorectal cancer (CRC) using various MS criteria in Novosibirsk population. Materials and Methods. The study was designed as nested «case-control». Baseline population cohort (93...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Tatiana M. Nikitenko, Lilia V. Shcherbakova, Sofia K. Malyutina, Svetlana V. Mustafina, Eugene G. Verevkin, Yuliya I. Ragino, Vladimir E. Voytsitsky, Anna V. Pyatibratova, Oksana D. Rymar
Format: Artigo
Langue:Inglês
Publié: Endocrinology Research Centre 2017-09-01
Collection:Ожирение и метаболизм
Sujets:
metabolic syndrome
colorectal cancer
the components of the metabolic syndrome
colon and rectum cancer
Accès en ligne:https://www.omet-endojournals.ru/jour/article/view/8178
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires